Company Profile
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Latest News
Ipsen’s Bylvay fails in Phase III biliary atresia study
Rothschild & Co Redburn Adjusts PT on Honeywell International to $216 From $214, Keeps Neutral Rating
JPMorgan Adjusts PT on Honeywell International to $262 From $250, Maintains Overweight Rating
Jefferies Adjusts Price Target on Teledyne Technologies to $830 From $775, Maintains Buy Rating
Goldman Sachs Adjusts PT on Teledyne Technologies to $877 From $858, Maintains Buy Rating
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.nihonkohden.com |
| Audit Risk | 1 |
| Board Risk | 3 |
| Overall Risk | 3 |
| Market Cap | 255.96B |
| Trailing P/E | 17.94 |
| Forward P/E | 14.57 |
| Dividend Rate | 33 |
| Dividend Yield | 2.18% |
| Trailing Annual Div. Rate | 32 |
| Trailing Annual Div. Yield | 2.11% |
| Trailing EPS | 89.17 |
| Forward EPS | 109.84 |
| Book Value | 1,123.46 |
| Price-to-Book | 1.42 |
| Enterprise-to-Revenue | 0.94 |
| Enterprise-to-EBITDA | 8.97 |
| Ex-Dividend Date | 09/29/2026 |
| Earnings Date | 08/06/2026 |
| Earnings Call Date | |
| Revenue Average | 47.91B |
| Revenue Low | 46.30B |
| Revenue High | 48.62B |